Tumor immune microenvironment of EGFR-mutant non-small-cell lung cancer and its impact on therapeutic efficacy

被引：4
|
作者：
Matsumoto, Yoshiya [1 ,2 ]
Koh, Yasuhiro [2 ]
机构：
[1] Osaka City Univ, Grad Sch Med, Dept Resp Med, Osaka, Japan
[2] Wakayama Med Univ, Internal Med 3, Wakayama, Japan
来源：
IMMUNOTHERAPY | 2020年 / 12卷 / 07期
关键词：
epidermal growth factor receptor; non-small-cell lung cancer; tumor microenvironment; tumor mutational burden; PD-L1; EXPRESSION; MUTATION INCIDENCE; OPEN-LABEL; PHASE IB; DOCETAXEL; NIVOLUMAB; ATEZOLIZUMAB; BLOCKADE; INFILTRATION; CHEMOTHERAPY;
D O I：
10.2217/imt-2019-0213
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：431 / 438
页数：8
相关论文
共 50 条
  • [41] Diffuse Lung Metastases in EGFR-Mutant Non-Small Cell Lung Cancer
    Digumarthy, Subba R.
    Mendoza, Dexter P.
    Padole, Atul
    Chen, Tianqi
    Peterson, P. Gabriel
    Piotrowska, Zofia
    Sequist, Lecia, V
    CANCERS, 2019, 11 (09)
  • [42] Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis
    Gen, Soei
    Tanaka, Ichidai
    Morise, Masahiro
    Koyama, Junji
    Kodama, Yuta
    Matsui, Akira
    Miyazawa, Ayako
    Hase, Tetsunari
    Hibino, Yoshitaka
    Yokoyama, Toshihiko
    Kimura, Tomoki
    Yoshida, Norio
    Sato, Mitsuo
    Hashimoto, Naozumi
    BMC CANCER, 2022, 22 (01)
  • [43] Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis
    Soei Gen
    Ichidai Tanaka
    Masahiro Morise
    Junji Koyama
    Yuta Kodama
    Akira Matsui
    Ayako Miyazawa
    Tetsunari Hase
    Yoshitaka Hibino
    Toshihiko Yokoyama
    Tomoki Kimura
    Norio Yoshida
    Mitsuo Sato
    Naozumi Hashimoto
    BMC Cancer, 22
  • [44] Therapeutic strategy for advanced EGFR mutant non-small-cell lung carcinoma
    Cadranel, Jacques
    Ruppert, Anne-Marie
    Beau-Faller, Michele
    Wislez, Marie
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 88 (03) : 477 - 493
  • [45] Aumolertinib with chemotherapy or alone compared with osimertinib in patients with EGFR-mutant non-small-cell lung cancer (TREBLE).
    Johnson, Melissa Lynne
    Miller, Vincent A.
    Patel, Suraj
    Zhao, Yumin
    Cheng, Li
    Ali, Siraj Mahamed
    Wooten, Michael
    Daniel, Davey B.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [46] BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer
    Karachaliou, Niki
    Codony-Servat, Jordi
    Teixido, Cristina
    Pilotto, Sara
    Drozdowskyj, Ana
    Codony-Servat, Caries
    Gimenez-Capitan, Ana
    Angel Molina-Vila, Miguel
    Bertran-Alamillo, Jordi
    Gervais, Radj
    Massuti, Bartomeu
    Moran, Teresa
    Majem, Margarita
    Felip, Enriqueta
    Carcereny, Enric
    Garcia-Campelo, Rosario
    Viteri, Santiago
    Gonzalez-Cao, Maria
    Morales-Espinosa, Daniela
    Verlicchin, Alberto
    Crisetti, Elisabetta
    Chaib, Imane
    Santarpia, Mariacarmela
    Luis Ramirez, Jose
    Bosch-Barrera, Joaquim
    Felipe Cardona, Andres
    de Marinis, Filippo
    Lopez-Vivanco, Guillermo
    Miguel Sanchez, Jose
    Vergnenegre, Alain
    Hernandez, Jose Javier Sanchez
    Sperduti, Isabella
    Bria, Emilio
    Rosell, Rafael
    SCIENTIFIC REPORTS, 2015, 5
  • [47] Prognostic value of EGFR genotype in EGFR-mutant non-small cell lung cancer
    Syrigos, Konstantinos
    Kotteas, Ilias
    Paraskeva, Maria
    Gkiozos, Ioannis
    Boura, Paraskevi
    Tsagouli, Sofia
    Grapsa, Dimitra
    Charpidou, Andriani
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [48] BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer
    Niki Karachaliou
    Jordi Codony-Servat
    Cristina Teixidó
    Sara Pilotto
    Ana Drozdowskyj
    Carles Codony-Servat
    Ana Giménez-Capitán
    Miguel Angel Molina-Vila
    Jordi Bertrán-Alamillo
    Radj Gervais
    Bartomeu Massuti
    Teresa Morán
    Margarita Majem
    Enriqueta Felip
    Enric Carcereny
    Rosario García-Campelo
    Santiago Viteri
    María González-Cao
    Daniela Morales-Espinosa
    Alberto Verlicchi
    Elisabetta Crisetti
    Imane Chaib
    Mariacarmela Santarpia
    José Luis Ramírez
    Joaquim Bosch-Barrera
    Andrés Felipe Cardona
    Filippo de Marinis
    Guillermo López-Vivanco
    José Miguel Sánchez
    Alain Vergnenegre
    José Javier Sánchez Hernández
    Isabella Sperduti
    Emilio Bria
    Rafael Rosell
    Scientific Reports, 5
  • [49] EGFR-Mutant Non-Small-Cell Lung Cancer at Surgical Stages: What Is the Place for Tyrosine Kinase Inhibitors?
    Cansouline, Xavier
    Lipan, Beatrice
    Sizaret, Damien
    Tallet, Anne
    Vandier, Christophe
    Carmier, Delphine
    Legras, Antoine
    CANCERS, 2022, 14 (09)
  • [50] Spatiotemporal T790M Heterogeneity in a Patient with EGFR-Mutant Non-Small-Cell Lung Cancer
    Hata, Akito
    Masago, Katsuhiro
    Katakami, Nobuyuki
    Imai, Yukihiro
    Yatabe, Yasushi
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (08) : E64 - E65
12345